Profile data is unavailable for this security.
About the company
SoftOx Solutions AS is a Norway-based medtech and biotech company, that develops products to help fight infections from viruses, biofilm resistance and antimicrobial resistance. It is a developer of infection control solutions for disinfection, wound care and the respiratory tract. The current business segments can be divided into: Wounds, Disinfection and Respiratory. SoftOx Solutions is engaged in the development of a range of products that can be classified as either medical devices or medicinal products for human use. SoftOx’s product portfolio includes such products as SafeDes+, a hand disinfectant for irritated, compromised and eczematous skin. The Company has several subsidiaries, including SoftOx Disinfection AS, SoftOx Defense Solutions AS and SoftOx Denmark AS.
- Revenue in NOK (TTM)13.59m
- Net income in NOK-3.00m
- Incorporated2012
- Employees5.00
- LocationSoftOx Solutions ASMartin Linges vei 25FORNEBU 1364NorwayNOR
- Websitehttps://soft-ox.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lifecare ASA | 1.82m | -123.69m | 93.24m | 28.00 | -- | -- | -- | 51.12 | -2.48 | -2.48 | 0.0379 | -0.11 | 0.0168 | -- | 0.1582 | 55,272.73 | -115.30 | -52.64 | -194.19 | -61.98 | -- | -- | -6,864.75 | -277.39 | -- | -- | 1.17 | -- | -26.10 | 36.13 | -103.52 | -- | -- | -- |
| Biosergen AB | 0.00 | -43.00m | 94.99m | 1.00 | -- | -- | -- | -- | -17.68 | -17.68 | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -112.64 | -- | -- | -- |
| Coegin Pharma AB | 0.00 | -21.75m | 102.47m | 3.00 | -- | 8.35 | -- | -- | -0.7859 | -0.7859 | 0.00 | 0.4681 | 0.00 | -- | -- | 0.00 | -85.07 | -133.34 | -91.51 | -179.59 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 15.00 | -- | -- | -- |
| Glycorex Transplantation AB (publ) | 42.07m | -7.44m | 107.49m | 20.00 | -- | 2.86 | 43.37 | 2.55 | -0.0917 | -0.0917 | 0.5174 | 0.4719 | 0.7442 | 1.45 | 5.20 | 1,997,000.00 | -13.15 | -15.79 | -17.51 | -18.66 | 81.68 | 87.06 | -17.67 | -44.85 | 1.56 | -15.83 | 0.1599 | -- | 17.35 | -0.5296 | 63.97 | -- | -- | -- |
| Exact Therapeutics AS | 0.00 | -72.20m | 107.55m | 12.00 | -- | 1.59 | -- | -- | -1.40 | -1.40 | 0.00 | 1.07 | 0.00 | -- | -- | 0.00 | -108.82 | -43.50 | -168.39 | -50.76 | -- | -- | -- | -- | -- | -20.18 | 0.0052 | -- | -- | -- | -8.27 | -- | 1.47 | -- |
| Alzinova AB | 215.95k | -28.32m | 108.14m | 5.00 | -- | 0.5018 | -- | 500.75 | -0.2846 | -0.2846 | 0.0022 | 1.23 | 0.0015 | -- | 0.3254 | 41,000.00 | -19.42 | -12.21 | -20.69 | -12.85 | -5,834.15 | -- | -13,114.15 | -21,390.81 | -- | -1,794.80 | 0.0062 | -- | -88.89 | -- | -24.71 | -- | 19.48 | -- |
| Biovica International AB | 10.39m | -80.56m | 109.62m | 24.00 | -- | 0.8842 | -- | 10.55 | -0.6375 | -0.6375 | 0.0684 | 0.4241 | 0.0799 | 12.71 | 4.46 | 365,333.30 | -61.92 | -58.22 | -70.41 | -66.49 | -171.53 | -462.09 | -775.22 | -1,804.16 | 8.11 | -- | 0.0239 | -- | 18.23 | 38.83 | 29.80 | -- | -47.26 | -- |
| Alligator Bioscience AB | 541.46k | -54.09m | 112.28m | 13.00 | -- | 1.27 | -- | 207.36 | -1.09 | -1.09 | 0.0074 | 0.1566 | 0.0048 | -- | 1.98 | -- | -47.78 | -101.41 | -- | -222.85 | -- | -- | -9,990.27 | -526.56 | -- | -- | 0.8354 | -- | -99.11 | -34.77 | 78.05 | -- | 70.30 | -- |
| Abera Bioscience AB | 0.00 | -11.01m | 113.83m | 5.00 | -- | 5.60 | -- | -- | -0.5692 | -0.5692 | 0.00 | 1.04 | 0.00 | -- | -- | -- | -49.58 | -63.36 | -74.82 | -81.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -850.27 | -- | -- | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -38.86m | 116.01m | 4.00 | -- | 4.42 | -- | -- | -5.98 | -5.98 | 0.00 | 3.53 | 0.00 | -- | -- | 0.00 | -150.00 | -137.53 | -190.93 | -169.50 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 26.58 | -- | -- | -- |
| Xbrane Biopharma AB | 160.49m | -48.63m | 137.84m | 29.00 | -- | 0.2334 | -- | 0.8588 | -106.73 | 1,665.76 | 29.07 | 27.21 | 0.2013 | 0.2847 | 12.91 | 5,253,586.00 | -6.10 | -25.02 | -10.00 | -43.04 | 58.77 | -- | -30.30 | -144.31 | 3.43 | -1.80 | 0.0942 | -- | 2.87 | -- | 67.33 | -- | 105.02 | -- |
| SoftOx Solutions AS | 13.59m | -3.00m | 141.25m | 5.00 | -- | 1.30 | 175.39 | 10.39 | -0.001 | -0.001 | 0.0065 | 0.0445 | 0.123 | -- | 30.13 | 2,717,798.00 | -2.72 | -50.91 | -3.22 | -67.07 | -- | -- | -22.07 | -644.92 | 1.16 | -3.92 | 0.1212 | -- | 13.38 | 14.06 | -8.86 | -- | -- | -- |
| Active Biotech AB publ | 0.00 | -39.29m | 152.45m | 5.00 | -- | 2.60 | -- | -- | -0.0236 | -0.0236 | 0.00 | 0.0211 | 0.00 | -- | -- | 0.00 | -65.79 | -93.70 | -82.91 | -119.51 | -- | -- | -- | -- | -- | -- | 0.0018 | -- | -- | -- | 5.33 | -- | -- | -- |
| NextCell Pharma AB | 11.52m | -37.02m | 165.46m | 24.00 | -- | 2.37 | -- | 14.36 | -0.4414 | -0.4414 | 0.133 | 0.596 | 0.1384 | 51.23 | 4.68 | -- | -44.48 | -34.95 | -49.25 | -37.53 | -155.37 | -266.34 | -321.31 | -427.08 | 9.92 | -- | -- | -- | 2.56 | 25.13 | 16.25 | -- | 36.88 | -- |
| ViroGates A/S | 7.58m | -18.63m | 171.75m | 7.00 | -- | 33.56 | -- | 22.65 | -1.63 | -1.63 | 0.6609 | 0.3665 | 0.3568 | 0.9777 | 4.41 | 504,300.00 | -87.63 | -54.92 | -131.36 | -63.15 | 47.33 | 72.98 | -245.63 | -215.48 | 1.58 | -16.13 | 0.6277 | -- | -12.27 | 6.45 | -18.59 | -- | -- | -- |
| Oncoinvent ASA | 5.41m | -107.58m | 189.88m | 7.00 | -- | 0.386 | -- | 35.13 | -176.33 | -176.33 | 8.86 | 109.85 | 0.0354 | -- | 0.4134 | 360,333.30 | -70.49 | -68.76 | -88.81 | -82.93 | -- | -- | -1,990.44 | -40,397.77 | -- | -- | 0.00 | -- | 139.55 | -37.51 | 26.85 | -- | -- | -- |
Data as of Feb 27 2026. Currency figures normalised to SoftOx Solutions AS's reporting currency: Norwegian Krone NOK
